RxDoctor Payments Data

Shih-Ting Chiu, PA

Surgical · Los Gatos, CANPI 1164758108

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $8,167 of the $9,703 with a category attached, or 84.2%. It is spread thinly across 25 manufacturers, the largest accounting for just 21.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $4,041 and has fallen 98.9% since, to $46 in 2025. Among surgical clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$9,703in general payments, 2019–2025

Across 263 payments — averaging $36.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Regeneron Healthcare Solutions, Inc.$2K
  • AbbVie$2K
  • Sanofi$794
  • LEO Pharma Inc.$712
  • Johnson & Johnson$706
  • Incyte Corporation$677
  • plus $3K from 19 others

What the payments were for

  • Consulting fees$1,16612%
  • Speaking & faculty fees$1381%
  • Food & beverage$8,16784%
  • Education$2332%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,703 in reported general payments places this provider in the 95th percentile of 729 surgical providers in California.

See all surgical providers in California

Medicare billing

Part B allowed, 2024
$4,574,817
Medicare patients
13
Services billed
2,575

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OtezlaApremilast35$155,548
Cosentyx Sensoready (2 Pens)Secukinumab11$73,181
Dupixent PenDupilumab12$43,847
Amjevita(Cf) AutoinjectorAdalimumab-Atto12$12,230
Tacrolimus49$5,838
Fluocinolone Acetonide79$5,499
Fluorouracil126$4,736
Clobetasol Propionate114$2,906
Calcipotriene33$2,609
Ketoconazole96$2,125
Mupirocin85$1,143
Hydrocortisone56$962
Doxycycline Monohydrate44$961
Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc21$920
Clindamycin Phosphate33$855

Paid to pharmacies, not to this prescriber.

Other surgical in Los Gatos

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →